The severity of immune-mediated intestinal diseases such as graft-versus-host disease (GVHD) or inflammatory bowel diseases is known to be associated with alterations in the gut microbiome, but what leads to such disruption ...
Feb 2, 2023
0
21
If you've ever tried giftwrapping an odd-shaped present like a teddy bear, you can appreciate the challenge that surgeons face when grafting artificial skin onto an injured body part. Like wrapping paper, engineered skin ...
Jan 31, 2023
0
52
Blood vessel replacements (vascular grafts) are used today for hemodialysis blood access, trauma repair and cardiovascular reconstruction. The first synthetic vascular grafts (blood vessel replacements) were developed just ...
Jan 30, 2023
0
10
New research challenges the prevailing hypothesis for how donor stem cell grafts cause graft-versus-host disease, or GVHD, and offers an alternative model that could guide development of novel therapies.
Jan 30, 2023
0
26
Northwestern Medicine scientists have discovered the pathways through which autoantibodies—immune proteins that mistakenly attack a person's own body—leak out of blood vessels and cause primary graft dysfunction in some ...
Nov 18, 2022
0
12
Organ damage occurs in up to 70% of patients in the first few months following stem cell transplant. The precise reasons for this potentially life-threatening reaction have long been the subject of scientific research.
Oct 13, 2022
0
40
A new, creative and innovative, minimally invasive skin-stretching device provides a promising alternative for surgical treatment of large scalp defects, reports a paper in The Journal of Craniofacial Surgery.
Oct 11, 2022
0
2
New research shows how doctors can improve the timing of surgery for some heart attack patients by analyzing the levels of a particular protein.
Oct 3, 2022
0
75
UCLA researchers report a step forward in the development of an "off-the-shelf" cell therapy that could reduce the severity of graft-versus-host disease in people receiving donor bone marrow transplants for the treatment ...
Sep 6, 2022
0
57
Tohid Didar and Jeff Weitz had a solution, but they also had a problem.
Aug 11, 2022
0
35
